Registration
ACCELERON PHARMA INC for ACCELERON PHARMA INC
Firm
Client
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Patient access to innovative biopharmaceuticals, pricing and reimbursement of medicines (HR 3), barriers to patient access via utilization management tools such as step therapy (HR 2163), FDA issues such as Accelerated Approval program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG CHESMORE New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.